ecancer
The International Agency for Research on Cancer has estimated that about half of all cancers could be avoided if current knowledge was adequately implemented.ecancer is a UK charity, working tirelessly to ensure current knowledge is properly shared. Our mission is to raise the standards of global cancer care through education.
We were founded in 2007 by two inspirational oncologists, Prof Gordon McVie and Prof Umberto Veronesi. Frustrated by global inequalities in access to education and research, they were driven to create an open platform to share knowledge that would help raise the standards of cancer care - ecancer.org.
- 5:10
- Күн бұрын
Linvoseltamab can be a potentially effective treatment option for patients with relapsed/refract...
- 2:05
- Күн бұрын
Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy...
- 3:34
- Күн бұрын
Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC
- 6:35
- Күн бұрын
TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and ...
- 6:14
- Күн бұрын
Neoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanoma
- 3:11
- Күн бұрын
Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma
- 4:52
- Күн бұрын
Cancer mutation prediction using AI
- 24:35
- Күн бұрын
ESMO 2024: Highlights and analysis
- 4:00
- Күн бұрын
Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer
- 8:59
- Күн бұрын
Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectab...
- 3:16
- Күн бұрын
Retifanlimab plus chemo shows PFS benefit in recurrent or metastatic squamous cell carcinoma of ...
- 3:34
- Күн бұрын
Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS
- 1:31
- Күн бұрын
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
- 3:04
- Күн бұрын
Пікірлер